Titlebook: Medical Treatment of Glaucoma; Xinghuai Sun,Yi Dai Book 2019 Springer Nature Singapore Pte Ltd. 2019 Glaucoma.Pharmacology.Aqueous humor d

Callow

書目名稱Medical Treatment of Glaucoma影響因子(影響力)




書目名稱Medical Treatment of Glaucoma影響因子(影響力)學(xué)科排名




書目名稱Medical Treatment of Glaucoma網(wǎng)絡(luò)公開度




書目名稱Medical Treatment of Glaucoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Medical Treatment of Glaucoma被引頻次




書目名稱Medical Treatment of Glaucoma被引頻次學(xué)科排名




書目名稱Medical Treatment of Glaucoma年度引用




書目名稱Medical Treatment of Glaucoma年度引用學(xué)科排名




書目名稱Medical Treatment of Glaucoma讀者反饋




書目名稱Medical Treatment of Glaucoma讀者反饋學(xué)科排名

傻瓜

Mechanism Theories of Glaucoma,on) along with loss of the nerve fibres. This leads to peripheral and finally total visual field loss. The major risk factor is elevated IOP, which along with cerebrospinal fluid pressure (CSFP) largely determines the pressure gradient and forces acting upon the connective tissue, nerve fibres and v

Promotion

Briefs on Evaluation Techniques for Glaucoma,terior chamber angle, optic nerve head, and visual function. This chapter will focus briefly on the assessment of such parameters, including different tonometry and its influencing factors for IOP; gonioscopy, UBM, and AS-OCT for anterior chamber angle; ophthalmoscopy, fund photography, and OCT for

AGGER

Medical Treatment Strategy for Glaucoma,” “medication or surgery,” and “switch or add.” There are no gold standard answers to these questions. Treatment decisions are usually based on comprehensive evaluation of the type and stage of the disease, medical history, general condition, life habits, and life expectancy of the particular patien

Indecisive

Medical Therapy for Glaucoma-IOP Lowering Agents,dications can be split into two groups: those that suppress aqueous production, and those that enhance aqueous outflow. Multiple formulations and combinations now exist in order to limit side effects and improve adherence. This chapter will review glaucoma medications that are currently available, t

breadth

減去

Novel Therapeutic Targets for Glaucoma: Disease Modification Treatment, Neuroprotection, and Neuror the underlying mechanisms of pathogenesis or pathophysiology of the disease. Therefore, they do not alter the progression of the glaucomatous pathological changes. In contrast, this chapter explores potential therapeutic targets that aim to correct and/or reverse the pathological changes based on o

Glossy

Clinical Practice Considerations,re glaucoma are different from that of primary open-angle glaucoma. The main types of secondary glaucoma and their underlying causes, treatment principles, and medication options are discussed in this chapter. Treatment of secondary glaucoma should be directed at blocking the underlying disease proc

BAN

Obstruction

nded to be useful to students of medicine preparing to sit for various national proficiency examinations, which include, as part of their content, the basic science of pathology. In the context of its usage here, pathology refers to an amalgamation of the general and systemic disciplines of the subj